Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 300, Taiwan.
Sci Rep. 2020 Aug 27;10(1):14230. doi: 10.1038/s41598-020-70903-4.
Detecting clinically relevant diagnostic biomarkers, suitable for point-of-care detection, may facilitate rapid treatment and prevention of disease. However, medical diagnosis for which there are limited quantities of testable tissue or fluid, require point-of-care technologies with superior sensitivity and specificity. The purpose of this Editorial is to provide an overview of the Collection’s content, comprising original research into fluidics-based diagnostic platforms—specifically those made of paper or other low-cost materials, that can suitably operate with tiny sample volumes from mL to nL. In particular, we will focus on the clinical applications of such research, with potential uses in a number of fields including combating the COVID-19 pandemic for instance.
检测具有临床意义的诊断生物标志物,适合即时检测,可能有助于快速治疗和预防疾病。然而,对于那些可检测的组织或液体数量有限的医学诊断,则需要具有更高灵敏度和特异性的即时检测技术。本社论的目的是概述该专集的内容,其中包括基于流体的诊断平台的原始研究,特别是那些由纸张或其他低成本材料制成的平台,这些平台可以适当地处理从 mL 到 nL 的小体积样本。特别地,我们将重点关注此类研究的临床应用,例如在抗击 COVID-19 大流行等多个领域具有潜在用途。